Chordomas located primarily in the sellar region are uncommon, and may be misdiagnosed non-functioning pituitary adenoma. Furthermore, the association of a persistent primitive trigeminal artery (PPTA) with an intrasellar chordoma is extremely rare, and no similar cases have been reported in the literature to date. The coexistence of intrasellar chordoma (ISC) and PPTA makes safe and complete tumor resection challenging, and preoperative endovascular occlusion of this artery may be helpful.
INTRODUCTION
Chordomas are midline neoplasms that originate from ectopic cells of notochordal remnants (18, 22) . The trigeminal artery (TA) is an anastomosis between embryonic precursors of the vertebrobasilar and carotid systems, and may persist into adult life (3) . It is the most common type of persistent primitive artery and is present in 0.1-0.6% of individuals (3, 4) . Chordomas located primarily in the sellar region are uncommon, and may clinically present as non-functioning pituitary adenoma (13) . To date, only 38 cases of ISC have been documented in the literature. Persistent primitive trigeminal artery (PPTA) has been reported to be associated with various vascular abnormalities such as brain aneurysms and arteriovenous malformations (AVMs), but rarely with tumors (4) . The association of PPTA with intrasellar chordoma (ISC) is extremely rare, and only one case of a clival chordoma associated with PPTA has been previously reported.
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We report a case of a primary ISC associated with PPTA, which was preoperatively occluded using endovascular techniques, permitting further surgical resection of the tumor. Despite a recent review that described only 22 patients with primary ISC since 1960, our extensive retrospective review of the literature yielded 16 additional cases of chordoma with sellar involvement (15, 44) .
CASE REPORT
A 32-year-old male presented to our outpatient clinic for surgical evaluation of a large sellar mass. He complained of intermittent retro-orbital headache, diplopia and right facial paresthesias. On physical examination, a right cranial nerve (CN) six palsy was observed, albeit there were no symptoms or signs of pituitary dysfunction. Ophthalmological examination revealed a right-sided afferent pupillary defect, a left temporal homonymous hemianopsia, and horizontal diplopia.
Computed tomographic (CT) scans revealed a large heterogeneous contrast-enhancing intrasellar mass (2.5 x 3.4 x 2.8 cm) with parasellar extension to the cavernous sinus, invasion of the sphenoid sinus, as well as erosion of the dorsum sellae and the sellar floor ( Figure 1A, B) . High resolution 1.5T magnetic resonance imaging (MRI) demonstrated that the lesion elevated and stretched the optic chiasm, protruded into both cavernous sinuses, and extended posteriorly to the prepontine cistern close to the basilar artery. The lesion enhanced heterogeneously after gadolinium administration, and exhibited moderate peripheral enhancement ( Figure  1C, D) . A vessel-like structure was also identified within the tumor, extending from the right intracavernous internal carotid artery to the basilar artery, corresponding to a PPTA ( Figure 1E ). Because of these findings, cerebral angiography was performed and demonstrated that the basilar and carotid arteries proximal and distal to the PPTA were both well-developed; the left posterior cerebral comunicating artery (PCoA) was permeable and right vertebral artery was hypoplastic. Balloon test occlusion (BTO) of the PPTA at 15 minutes did not reveal neurological changes. A microcatheter was subsequently used to catheterize the PPTA through the right vertebral artery, and 16 cm of coils were delivered for complete occlusion of the PPTA ( Figure 1F ).
Despite a slightly elevated basal prolactin level (26.4 ng/ mL, reference value 3.5-19.5 ng/mL) other endocrinological investigations of pituitary function were normal. Based on the endocrinological evaluation as well as preoperative CT, MRI, and cerebral angiography, the presumed diagnosis of the lesion was ISC or chondrosarcoma associated with PPTA.
The patient underwent surgery for tumor resection, using a sublabial transsphenoidal (TSS) approach guided by neuronavigation. After opening the dura, a yellow, encapsulated, and soft lesion with a necrotic component was seen protruding into the sphenoid sinus. The tumor was debulked using microsurgical technique with bipolar forceps and pituitary curettes. The lateral and posterior limits of the lesion were moderately hemorrhagic and exhibited a rubbery consistency. The portion of the tumor adherent to the medial walls of the cavernous sinus could not be resected safely and so a subtotal resection was achieved.
Light microscopy revealed a solid pattern of cells arranged in cords. Neoplastic cells appeared embedded in a myxoid intercellular matrix and exhibited large, round eosinophilic cytoplasm containing multiple vacuoles, characterizing typical physaliphorous cells (Figure 2A , B). Immunohistochemical (IHC) analysis showed strong positivity for cytokeratin AE1-AE3 as well as endothelial membrane antigen (EMA) ( Figure  2C , D). The final pathological diagnosis was ISC.
Postoperatively, the patient did well and had no endocrinological impairments, except for transient diabetes insipidus. The patient experienced significant improvement of his right hemifacial paresthesias, diplopia and visual field deficit. MR Table I summarises the clinical information recorded from the cases of ISC included in this study.
Neuroradiographical imaging features are useful in the preoperative diagnosis of skull base chordomas. On CT scans, these tumors are seen as slow-growing masses with bony erosion and calcifications or bone fragments within the tumor (5). CT can be more useful than MRI for detecting calcified masses such as chordoma (5, 45) . On MRI chordomas usually appear hypointense on T1-weighted images (T1WI), whereas T2WI shows high-signal intensity. Calcifications or bone fragments appear as low-intensity areas in the tumor (5, 19) .
After gadolinium administration, ISC shows heterogeneous enhancement (15, 31) . Additional studies with dynamic MR imaging and spectroscopy may help differentiate ISC from other skull base lesions (27, 44) .
Histologically, chordomas are composed of lobules separated by fibrous tissue and neoplastic cells are arranged in cords, columns, or trabeculae. Ultrastructurally, chordomas lack malignant features such as necrosis or hemorrhage, although occasional mitotic figures and cellular pleomorphism may be present, that is of no prognostic significance (5, 15, 44) . The immunohistochemical profile of chordomas includes reactivity to cytokeratins, vimentin, and epithelial membrane antigen (EMA) (15) . Chordomas containing a cartilaginous matrix are classified as chondroid chordoma (14) .
The current published literature regarding the management of intracranial chordomas is mixed, but most authors agree that optimal treatment consists of gross-total surgical resection followed by high-dose local radiation therapy (1, 12, 34, 36) . Gross-total resection is challenging, however, and can rarely be achieved given the anatomical constraints and infiltrative nature of the lesion. Subsequently, Crockard et al proposed that the surgical goal should be maximal, safe cytoreduction, with the least collateral damage (7) . In study performed four months after the surgical procedure displayed subtotal tumor removal as well as optic chiasm and pons decompression ( Figure 3A -C). Six months after surgery, the patient remained asymptomatic and was referred to the oncology department for radiotherapy.
DISCUSSION
Chordomas are rare, slow-growing malignant tumors that arise from remnants of the notochord and consequently are located rostrally and caudally along the midline of the neuroaxis (6, 15, 27, 44) . Chordomas represent approximately 2% of all malignant tumors of the bone and 0.1% to 0.2% of all intracranial neoplasms (42). The incidence of intracranial chordomas shows a slight male predilection (6:5) and they often appear in younger patients. Approximately 50% of chordomas develop in the sacrococcygeal region, 35% in the sphenoccipital region, and 15% in spinal vertebrae (15, 22) . Chordomas primary involving the sellar region are rare (15) .
The trigeminal artery is the largest of the fetal carotidbasilar anastomotic arteries. It persists for the longest embryonic period and is usually obliterated by the 11.5 to 14 mm embryonic stage, after the development of PCoA. Additionally, it is the most common of the primitive carotidbasilar anastomoses that persist into adulthood, with an estimated incidence of 0.1% to 1% on cerebral angiograms (3). PPTA has been reported to be associated with various vascular abnormalities, such as brain aneurysms and arteriovenous malformations (AVMs), and only rarely has it been described together with central nervous system (CNS) tumors (4). In fact, our case is only the second to describe a chordoma associated with PPTA. Baltsavias et al. reported the first case of a co-existing clival chordoma and PPTA that was lacerated during surgery (4). Thus, the present case is the first to document ISC associated with a PPTA.
A recent review by Hirosawa et al reported on 22 patients with ISC (15, 44) . In the present study, however, we performed a systematic review of all cases of primary ISC previously (23, 32, 34, 40) . In cases of ISC, TSS and EEE approaches have been advocated allowing satisfactory tumor resection as well as decompression of the suprasellar compartment, optic chiasm and cavernous sinus (17, 26, 34) . The transcranial route was used widely throughout the 1950s and 1960s, perhaps following Cushing´s abandonment of TSS (7, 28) . Today, a transcranial approach may be indicated in cases of ISC with lateral suprasellar extension or in the setting of sphenoid sinusitis or ecstatic midline carotid arteries where a transnasal approach is contraindicated (7, 28) . Our outcomes analysis of ISC cases summarized in Table I demonstrated a higher mortality rate in patients who underwent craniotomy (5 mortalities) versus TSS (1 mortality).
Because of the close proximity of skull base chordomas to vital structures and infiltrative nature of the tumor, the majority of chordoma resections are incomplete, and adjuvant radiation therapy is usually recommended (44) . Conventional fractionated radiotherapy has been most commonly used, although there have been advancements in photon therapy (Gamma Knife, CyberKnife, and IMRT) that have helped to avoid excessive dosing to surrounding skull base tissues (1) . Postoperative radiotherapy has been recommended to prolong disease-free survival, but its effect on improving overall survival is not well-established (18, 44) .
Intraoperatorive hemorrhage from vascular structures, like the cavernous sinus, ICA, basilar artery, and persistence primitive vessels, may be potentially fatal and one of the most feared complications of TSS or EEE approaches. Subsequently, relationships of skull base tumors to intracranial vessels, should be carefully evaluated preoperatively with an angiogram, particularly when those surgical approaches are used (3) . The decision to occlude PPTA must take into account the particular anatomical variation, branches, and its association with other cerebrovascular variants and disorders, all of which determine the safety of such a procedure (3, 4) . This paper provides new insight into the need of suitable preoperative management of primitive carotid-basilar anastomoses that persist into adulthood before attempting surgical removal of sellar tumors, in order to achieve extensive surgical resection avoiding intraoperative life-threatening vascular complications.
CONCLUSION
Chordomas arising primarily in the sella turcica are rare lesions that may be misdiagnosed as non-functional pituitary adenoma. The association of ISC with PTTA is even more exceptional. Accurate preoperative diagnosis of ISC with vascular anomalies using MRI alone remains challenging because of its low incidence. For this reason, preoperative angiography may be indicated in select cases in order to allow for possible endovascular occlusion of the vascular anomaly
